Vineet Laboratories Limited has announced that it has received in-principle approval from both the National Stock Exchange of India (NSE) and BSE Limited for undertaking a Rights Issue of Fully Paid-up Equity Shares. The NSE granted its approval on December 02, 2025, and BSE Limited provided its approval on December 16, 2025. As per the announcement, the company's Board of Directors (or a committee thereof) is scheduled to meet on December 17, 2025, to consider and approve key modalities of the proposed Rights Issue. These will include the Issue Price, Entitlement Ratio, Record date, Issue opening and closing dates, and other related aspects. The rights issue is proposed to be up to ₹30 Crores on a rights basis to eligible equity shareholders in a specific ratio, with a face value of ₹10 per equity share. Both exchanges have outlined conditions for final approval, including compliance with SEBI regulations, statutory approvals, and other applicable laws. The company is permitted to use the exchanges' names in its Letter of Offer, provided specific disclaimer clauses are included, emphasizing that the exchanges have not endorsed the correctness or completeness of the offer document.